Journal profile · Hematology
British Journal of Haematology
ISSN 0007-1048 · eISSN 1365-2141 · Wiley-Blackwell Publishing Ltd · ENGLAND · Semimonthly · Founded 1955
British Journal of Haematology: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 3.58; hybrid open access; APC about USD 5,190; median 91 days to acceptance (115 articles, last 24 months); community-reported acceptance: fairly easy; 611 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
British Journal of Haematology is published by Wiley-Blackwell Publishing Ltd and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment and Platelet Disorders and Treatments, together about 23% of its articles. Its main subfields are Hematology and Genetics. (generated from OpenAlex topic counts and CAS ranking data)
The mission of the British Journal of Haematology (BJHaem) is to inform and educate its readership in all aspects of the clinical and laboratory practice of haematology, extending from its scientific basis, through translational research, to clinical trials and daily practice. The journal welcomes manuscripts in new directions that change clinical practice from new therapies and diagnostic approaches, and including new therapies in translation and improved knowledge of disease processes.
From the journal's Aims & Scope
Research area (LetPub): Hematology
Editor-in-chief Andrew EvensPublisher website
Editorial board by country: 2 in mainland China (about 6%); most named United Kingdom 10, United States 9, Mainland China 2, France 2, Spain 2 (33 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Acute Myeloid Leukemia ResearchMedicine8.6%
- Lymphoma Diagnosis and TreatmentMedicine7.3%
- Platelet Disorders and TreatmentsMedicine7.2%
- Hemoglobinopathies and Related DisordersMedicine7.1%
- Chronic Lymphocytic Leukemia ResearchMedicine6.9%
- Blood groups and transfusionMedicine5.4%
- Acute Lymphoblastic Leukemia researchMedicine5.2%
- Hematopoietic Stem Cell TransplantationMedicine5.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Hematology | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Hematology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Hematology | Zone 2 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: EBSCO
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.58LetPub ·
- Impact factor (publisher) 2025
- 3.6Publisher website ·
- CiteScore 2026-06
- 6.6LetPub ·
- CiteScore (publisher) 2025
- 6.6Publisher website ·
- SJR 2026-06
- 1.46LetPub ·
- SNIP 2026-06
- 1.24LetPub ·
- h-index
- 172LetPub ·
- h-index
- 265OpenAlex ·
- i10-index
- 18,136OpenAlex ·
- 2-year mean citedness
- 2.72OpenAlex ·
- Self-citation rate
- 5.6%LetPub ·
- Share of gold OA articles
- 43.74%LetPub ·
Volume
- Articles per year
- 349LetPub ·
- Articles per year (publisher) 2025
- 574Publisher website ·
- Downloads per year (publisher) 2025
- 2,993,164Publisher website ·
Articles by year OpenAlex count · 30,110 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 568 | 411 | 137 |
| 2025 | 611 | 428 | 1,257 |
| 2024 | 710 | 503 | 3,735 |
| 2023 | 675 | 512 | 5,126 |
| 2022 | 632 | 332 | 6,280 |
| 2021 | 794 | 590 | 12,109 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
91 daysMedian, submission to acceptance · P25–P75 61 days – 132 days
- Acceptance to online
- median 16 days (117 articles)
- Submission to online
- median 114 days
- Sample
- 115 articles with submission and acceptance dates (1,341 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher) 2025
- 21%Publisher website ·
- Submission to first decision 2025
- 12 daysPublisher website ·
- Submission to acceptance 2025
- 99 daysPublisher website ·
- Acceptance to publication 2025
- 14 daysPublisher website ·
- Peer review
- Single-anonymous peer reviewPublisher website · model-extracted
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 5,190 / EUR 4,430 / GBP 3,730 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Reference style
- Vancouver
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
- Graphical abstract
- Optional
- Cover letter
- Required
Article types accepted10, with length limits
- bsh guidelines & good practice papersBSH Guidelines & Good Practice Papers Prepared by the BSH Guideline Committee and are subject to peer review like other submissions.Length not stated
- case reportArticle Type Description Format Original Papers This category includes original research in scientific, laboratory and clinical haematology. All papers are subj…Length not stated
- letterArticle Type Description Format Original Papers This category includes original research in scientific, laboratory and clinical haematology. All papers are subj…Length not stated
- original paperArticle Type Description Format Original Papers This category includes original research in scientific, laboratory and clinical haematology. All papers are subj…Length not stated
- original papersOriginal Papers This category includes original research in scientific, laboratory and clinical haematology. All papers are subject to peer review. Papers must …Length not stated
- original researchArticle Type Description Format Original Papers This category includes original research in scientific, laboratory and clinical haematology. All papers are subj…Length not stated
- other guidelines & practicesOther Guidelines & Practices Guidelines prepared by authoritative bodies other than the BSH.Length not stated
- research letterResearch Letter Research letters should cover important observations of value demonstrated by a more limited amount of data covering novel methodologies, therap…Length not stated
- reviewArticle Type Description Format Original Papers This category includes original research in scientific, laboratory and clinical haematology. All papers are subj…main text ≤ 5,000 words
- reviewsReviews Majority invited: manuscripts written by experts in the field on a topic of current interest to haematologists; should focus on the contemporary status …Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, License & copyright, Open access, Peer review
- Authorship 3. Authorship
All authors must fulfil the following criteria: Substantial contributions to research design, or the acquisition, analysis or interpretation of data, Drafting the paper or revising it critically, Approval of the submitted and final versions. In the Acknowledgments section of the paper all authors, must indicate their specific contributions to the work described in the manuscript. Some examples inc…
Source ↗Publisher website ·- Conflicts of interest Disclosure and competing interests statement
All authors must disclose competing interests, or state “none” via the Journal's submission website.
Source ↗Publisher website ·- Data availability Data availability statement
This journal expects data sharing. Please review Wiley’s Data Sharing policy for more information.
Source ↗Publisher website ·- License & copyright Copyright
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services, where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.
Source ↗Publisher website ·- Open access Open access
You will have the option to make your article open access after acceptance, which will be subject to an Article Publication Charge (APC) unless a waiver applies. Read more about APCs here.
Source ↗Publisher website ·- Peer review 6. The Review Process
The BJHaem aims for rapid turn-around of intermediate and final decisions on submitted manuscripts. Immediate negative decisions permit authors to quickly select other journals for resubmission. All manuscripts are first reviewed at the editorial office where they may be assigned to an Associate Editor, Letters Editor or Reviews Editor. Manuscripts are then usually sent for peer review. Decisions …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Semimonthly
- Founded
- 1955
- ISSN
- 0007-1048
- Electronic ISSN
- 1365-2141
- Society / sponsor
- British Society for Haematology
- Latest issue on the website
- Volume 7, Issue 5 (October 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about British Journal of Haematology
What CAS zone is British Journal of Haematology in?
In the 2025 upgraded edition of the CAS Journal Ranking, British Journal of Haematology is in Zone 2 of Medicine, and in Zone 2 of the minor category Hematology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of British Journal of Haematology?
The latest impact factor listed by LetPub is 3.58; CiteScore 6.6, h-index 265.
How long does peer review take at British Journal of Haematology?
Based on the dates recorded on 115 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 91 days (interquartile range 61–132 days); authors report an average review time of about 1 month; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 21% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of British Journal of Haematology?
According to the journal's author guidelines: Reference style: Vancouver; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of British Journal of Haematology based?
Of the 33 board members whose country the journal's board page names, 2 (about 6%) are in mainland China; the countries named most often are United Kingdom (10), United States (9) and Mainland China (2). Counted from the institutions listed on the board page; for reference only.
Which databases index British Journal of Haematology?
According to LetPub and DOAJ records, British Journal of Haematology is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is British Journal of Haematology open access, and what is the APC?
British Journal of Haematology is a hybrid journal. For open-access publication: APC about USD 5,190.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .